UkuHlola iingozi kunye neNzuzo
Izigulane ze-arthritis maxa wambi zivalo ngezinto eziphilayo , ezibizwa ngokuba yi-biologic response modifiers. Izidakamizwa zokuqala ze-biolog ezivunyiweyo yi-FDA zeentlobo ezivuthayo zesifo se-arthritis ziyizidakamizwa ezichasene ne-TNF , nazo zibizwa ngokuba yi-block block ye-TNF (tumor necrosis inhibitor). Kukho iziphumo ezinobungozi ezinxulumene ne-TNF blockers, ezifana nokusuleleka kwe-HIV kunye ne-lymphoma.
Kodwa, akufanelekanga yini ukulinganisela ingozi kunye neenzuzo zonyango nge-block blockers?
I-TNF blockers, ezibhekwa njenge-DMARD ye-biologic, ziquka i- Enbrel (etanercept), i- Humira (adalimumab), i- Remicade (infliximab), i- Simponi (golimumab) kunye neCimzia (certolizumab pegol). Bafumana inzuzo enhle kakhulu / mngcipheko. Ngamanye amagama, ngelixa iziphumo ezibi ziza kukhula, aziqhelekanga. Kwakhona kuyaphawuleka ukuba ezininzi izigulane zifumana uphuculo olubalulekileyo ekuthatheni iziyobisi.
I-block block ye-TNF iye yafundiswa kwizigulane kwiminyaka kwaye sele isemarike ukususela ngo-1998. Iinkxalabo ezimbini ezibalulekileyo ngala mayeza zibandakanya umngcipheko wokusuleleka kwintsholongwane okanye i-lymphoma. Ngaphandle kokuthatha i-TNF blockers, izigulane ze-rheumatoid arthritis zinomngcipheko wokwanda kwezi zimbini iingxaki (intsholongwane okanye i-lymphoma) xa kuthelekiswa noluntu jikelele. Enyanisweni, izigulane ezinesifo esibi kakhulu se-rheumatoid arthritis ziyakwazi ukuhlakulela i-lymphoma kunezo ezinezifo ezinzima.
Kukho ubungqina bokuba iziyobisi ze-biologic zandisa ingozi yokuvelisa izifo ezingavamile, ezifana nesifo sofuba (TB) . Ngako-ke, kucetyiswa ukuba zonke izigulane zihlolwe ngophando lwesikhumba kunye ne-x-ray esifubeni ukuze zihlolisise ukusukela kwi-TB ngaphambi kokuqala unyango nge-blocker ye-TNF.
Kufuneka uqaphele ngakumbi ngokuthatha ii-blockers ze-TNF ukuba unesifo seswekile esinesifo se-sululini okanye unesizathu esithile sokuba usengozini yokusuleleka kwintsholongwane, ukusuleleka kwezifo okanye izilonda ezivulekileyo okanye izilonda.
Izigulane ezininzi ze-rheumatoid zingenza kakuhle kwi- DMARD yendabuko, njenge- Plaquenil (hydroxychloroquine), i- Azulfidine (sulfasalazine) okanye i- Rheumatrex (methotrexate) kwaye ayinakuze ifune ukuthatha i-blocker ye-TNF. Kwizigulane ezinezifo ezibalulekileyo kwaye zinesizathu sokuba bangathathi i-methotrexate (umz., Isibetho sesibindi), ii-blockers ze-TNF zingasetyenziswa njengonyango lokuqala.
Ngaphantsi
Ukuba unikwe i-blocker ye-TNF kwaye uyavuma ukuzama, khumbula ukuba:
- Yazi iziphumo ezichaphazelekayo ezinxulumene ne-block blockers.
- Qaphela. Ukuqwalasela iimpawu ezintsha ezinokuthi zenziwe emva kokuqala i-blocker ye-TNF.
- Musa ukuphazamisa iimpawu ezintsha. Bika utshintsho kugqirha wakho kwaye ugqirha ugqirha wakho ukuba anqume ukubaluleka noko kufuneka kwenziwe.
- Nangona ukuqonda kunye nokuqapha kubalulekile xa uqala naluphi na isilwanyana esitsha, kwaye ngokukodwa enye eneempembelelo ezibi kakhulu, gcinani engqondweni ukuba ezininzi iziphumo okanye iimpendulo ezingathandekiyo aziqhelekanga. Nciphisa ukwesaba kwakho nge nyaniso.
- Xoxa ngezinto ozikhathazayo ngogqirha wakho. Ukulinganisa iintlawulo ngokumalunga neengozi zonyango nge-blocker ye-TNF. Cingisisa ubunzima beemeko zakho, izimo ezingenakuqhathaniswa kunye nezinye iindlela zokonyango. Kanye kunye nogqirha, qulunqa icebo uze uqonde iinjongo zonyango kunye noko kuya kuba yinkqubo yesenzo ukuba kukho into engalunganga.
Umthombo:
Impendulo enikeziwe, ngokwengxenye, nguScott J. Zashin, MD uDkt. Zashin unjingalwazi oncedisayo ekliniki kwiYunivesithi yaseTexas Southwestern Medical School kunye noogqirha kwiiNgqungquthela zasePresbyterian zaseDallas nasePlano. UDkt. Zashin ungumlobi weArthritis ngaphandle kobuhlungu - Ummangaliso we-TNF Blockers kunye nombhali-mbhali we- Natural Arthritis Treatment .